The Enterprise Value as of December 2024 (TTM) for AcelRx Pharmaceuticals, Inc. (ACRX) is -678100.00

According to AcelRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -678100.00. This represents a change of -104.76% compared to the average of 14.24M of the last 4 quarters.

AcelRx Pharmaceuticals, Inc. (ACRX) Historical Enterprise Value (quarterly & annually)

How has ACRX Enterprise Value performed in the past?

The mean historical Enterprise Value of AcelRx Pharmaceuticals, Inc. over the last ten years is 124.41M. The current -678100.00 Enterprise Value has changed -154.51% with respect to the historical average. Over the past ten years (40 quarters), ACRX's Enterprise Value was at its highest in in the March 2019 quarter at 313.70M. The Enterprise Value was at its lowest in in the September 2023 quarter at -3669095.52.

AcelRx Pharmaceuticals, Inc. (ACRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AcelRx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AcelRx Pharmaceuticals, Inc. (ACRX) Average Enterprise Value

How has ACRX Enterprise Value performed in the past?

The current Enterprise Value of AcelRx Pharmaceuticals, Inc. (ACRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AcelRx Pharmaceuticals, Inc. (ACRX) Enterprise Value vs. Peers

How is ACRX’s Enterprise Value compared to its peers?

AcelRx Pharmaceuticals, Inc.’s Enterprise Value is less than Mallinckrodt plc (2.67B), less than Lifecore Biomedical, Inc. (390.24M), less than Lucy Scientific Discovery Inc. (2.06M), less than Alimera Sciences, Inc. (362.58M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), less than Shuttle Pharmaceuticals Holdings, Inc. (3.03M), less than Catalent, Inc. (16.13B), less than Tilray Brands, Inc. (1.47B), less than Aquestive Therapeutics, Inc. (286.31M), less than Evoke Pharma, Inc. (1.03M), greater than Guardion Health Sciences, Inc. (-10475955.00), less than Organogenesis Holdings Inc. (413.14M), less than Agile Therapeutics, Inc. (7.87M), less than Assertio Holdings, Inc. (82.51M), less than Amneal Pharmaceuticals, Inc. (6.17B),

Build a custom stock screener for AcelRx Pharmaceuticals, Inc. (ACRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AcelRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AcelRx Pharmaceuticals, Inc. (ACRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AcelRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.